| Patents for C07C 233 - Carboxylic acid amides (28,881) |
|---|
| 02/20/2008 | EP1888509A1 Benzoyl-substituted serine amides |
| 02/20/2008 | EP1697304B1 Peroxisome proliferator activated receptor modulators |
| 02/20/2008 | CN101125833A Optically active bisoxazoline compounds, process for production of the same and use thereof |
| 02/20/2008 | CN100369888C N-alkanoylphenylalanine derivatives |
| 02/20/2008 | CN100369887C Inhibitors of oleamide hydrolase |
| 02/19/2008 | US7332631 Fc receptor modulating compounds and compositions |
| 02/19/2008 | US7332629 Amide derivatives of the compound anacardic acid from Cashew Nut Shell Oil; to treat cancer, AIDS, HIV infection, and asthma |
| 02/19/2008 | US7332524 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/19/2008 | US7332499 N-[(1R)-1-(2-fluoro-4-{1-[(trifluoromethyl)sulfonyl]-1,2,3,4-tetrahydroquinolin-8-yl}phenyl)ethyl]-1-[(trifluoroacetyl)amino]cyclopropanecarboxamide; bradykinin B1 antagonists or inverse agonists; analgesic and antiinflammatory agent; acute and chronic pain |
| 02/19/2008 | CA2281226C Process for synthesizing .alpha.-substituted ring systems |
| 02/14/2008 | WO2008018823A1 A process for the preparation of optically active cyclopropylamines |
| 02/14/2008 | WO2008018683A1 Hydroxycinnamic acid derivatives and preparation method thereof and cosmetic composition containing it |
| 02/14/2008 | WO2008017840A1 Cyclopentanecarboxylic acid derivatives and their use in the treatment of bacterial infectious diseases |
| 02/14/2008 | US20080039656 Synthesis and Application of Procainamide Analogs for Use in an Immunoassay |
| 02/14/2008 | US20080039655 Having dialkyl amide chains and alkylene oxide adduct functionality; compatibility with anionic and/or nonionic surfactants; cleaning power, mildness, detergency; softening and antistatic effects |
| 02/14/2008 | US20080039634 Novel onium salt, electrolyte for nonaqueous cell containing the novel onium salt for nonaqueous cell and method for optimizing negative electrode using electrolyte containing onium salt |
| 02/14/2008 | US20080039509 Histone Deacetylase Inhibitors or Novel Benzamine Derivatives with Potent Differentiation and Anti-Proliferation Activity |
| 02/14/2008 | US20080039506 Aminoalcohol Derivatives |
| 02/14/2008 | US20080038750 Multivalent Chelators for Modifying and Organizing of Target Molecules |
| 02/14/2008 | US20080038276 carbamimidoyl benzylamide derivatives; preventing and treating the formation of thrombin during or after a PK dependent disease or condition after fibrinolysis treatment |
| 02/14/2008 | US20080038213 1,3-Bis-[3-(4-methoxyphenyl)-2-propenoyloxy]-2-oxopropane; novel alpha-hydroxyketone derivatives as light-protection filters for cosmetic or drug products; used in cosmetic protective coatings; solar radiation; sunscreen agents; aging resistance; wrinkle resistance; food additives; dermatology |
| 02/14/2008 | CA2659091A1 A process for the preparation of optically active cyclopropylamines |
| 02/13/2008 | EP1886990A1 Phenyl-prenyl-ether derivatives for the treatment of cognitive neurodegenerative or neuronal diseases or disorders |
| 02/13/2008 | EP1885689A1 Diamondoid derivatives possessing therapeutic activity |
| 02/13/2008 | EP1885684A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta-2 adrenergic receptor |
| 02/13/2008 | EP1613589B1 Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter |
| 02/13/2008 | EP1292561B1 Process for the preparation of cyclopropyl carboxylic acid esters and derivatives |
| 02/13/2008 | CN101121674A Compound N-((2R,3S,E)-1,3-dihydroxy-17-methyloctadecyl-8-en-2-yl)acetamide |
| 02/13/2008 | CN101121673A Technique for synthesizing o-chloroacetaminophenol |
| 02/13/2008 | CN100368394C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 02/13/2008 | CN100368385C Tech. of preparing 2-amino-4-acetamido methyl-phenoxide |
| 02/12/2008 | US7329782 Compounds for the treatment of metabolic disorders |
| 02/12/2008 | US7329775 Compounds and related methods for mutant p53 reactivation |
| 02/12/2008 | US7329767 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof |
| 02/07/2008 | WO2008016883A2 Inhibitors of plasma kallikrein |
| 02/07/2008 | WO2008015241A1 Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 02/07/2008 | WO2008015133A2 Process for preparing amidrazones |
| 02/07/2008 | US20080033171 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants |
| 02/07/2008 | US20080033131 Imparting soil-release and anti-soiling characteristics to a textile by treatment with a copolymer of perfluorohydroalkenoylaminoalkyl (meth)acrylate and an acid or quaternary salt of an aminoalkyl (meth)acrylate; good water and oil repellencies |
| 02/07/2008 | US20080033042 Urea-and urethane-substituted acylureas, process for their preparation and their use |
| 02/07/2008 | US20080032920 Macromolecules modified with electrophilic groups and methods of making and using thereof |
| 02/07/2008 | US20080032417 Photocleavable isotope-coded affinity tags |
| 02/07/2008 | US20080032409 Fluorescent biomolecule labeling reagents |
| 02/07/2008 | US20080032288 Labeling Reagents, Methods for the Synthesis of Such Reagents and Methods for the Detection of Biological Molecules |
| 02/07/2008 | CA2658552A1 Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 02/06/2008 | EP1883402A2 Hydroxybenzamide derivatives and their use as inhibitors of hsp90 |
| 02/06/2008 | CN101120094A Method for producing chiral alcohols |
| 02/06/2008 | CN101119963A Methamphetamine derivatives and conjugates for immunoassay |
| 02/06/2008 | CN101119962A Selective splitting of substituted bisbenzylamides and bisbenzylamines |
| 02/06/2008 | CN101119951A Modulator |
| 02/06/2008 | CN100366659C Weatherable polycarbonate comprising N, N'-oxanilide structural units, its preparation method, and products made therefrom |
| 02/06/2008 | CN100366605C Compounds to treat alzheimer's disease |
| 02/06/2008 | CN100366604C Method for functionalizing phenolic compound bearing electron-donor group |
| 02/06/2008 | CN100366603C Process for the preparation of N-substituted formamides |
| 02/05/2008 | US7326813 Process for producing benzylamine derivative |
| 02/05/2008 | US7326803 Skin disorders; antiinflammatory agents; antiproliferative agents; controlling metabolism; obesity; antilipemic agents; antihistamines |
| 02/05/2008 | US7326795 efficient resolution, purification and isolation of intermediate compounds, and a one step neutralization/coupling procedure |
| 02/05/2008 | US7326746 Curable electron donor compositions |
| 02/05/2008 | US7326732 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders |
| 02/05/2008 | US7326731 Muscarinic agonists |
| 02/05/2008 | US7326730 Aminoadamantane derivatives as therapeutic agents |
| 02/05/2008 | US7326510 Polycarbocyclic derivatives for modification of resist, optical and etch resistance properties |
| 02/05/2008 | US7326407 Amine, amide, sulphonamide and carbamate derivatives of benzalmalonic salts and photoprotective cosmetic compositions comprised thereof |
| 02/05/2008 | CA2284977C 3,3-disubstituted propylamines, their use and preparation |
| 01/31/2008 | WO2007143175A3 Combination of ceramide and oxaliplatin for inducing cell death and uses thereof in treating cancer |
| 01/31/2008 | US20080027229 Compounds for the treatment of metabolic disorders |
| 01/31/2008 | US20080027115 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof |
| 01/31/2008 | US20080027109 bis-[2-(pivaloylamino)phenyl]disulfide; cholesteryl ester transfer protein (CETP); atherosclerosis, hyperlipidemia |
| 01/31/2008 | US20080027060 Dipeptide nitriles |
| 01/31/2008 | US20080026407 Covalent tethering of functional groups to proteins |
| 01/31/2008 | US20080025940 Administration of 3-sulfanylpropanamide compounds for stimulating hair and eyelash growth and/or for stopping the loss and/or limiting the depigmentation thereof |
| 01/31/2008 | CA2658887A1 Fatty acid amide hydrolase inhibitors |
| 01/30/2008 | CN101115710A Diamine calcium channel blockers |
| 01/29/2008 | US7323608 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2008 | US7323595 Ink jet printing, reacting benzylamine-aldehyde compound with stearyl cyanoacetamide |
| 01/29/2008 | US7323594 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 01/29/2008 | CA2297417C Derivatives of acyl-piperazinyl-pyrimidines, their preparation and application as medicaments |
| 01/29/2008 | CA2271735C Magnetic resonance blood pool agents |
| 01/29/2008 | CA2220999C Process for the hydrogenation of imines |
| 01/24/2008 | WO2007143014A3 Methods for preparing glutamic acid derivatives and intermediates thereof |
| 01/24/2008 | WO2007103719A3 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 01/24/2008 | US20080021109 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/24/2008 | US20080020981 Non-nucleoside reverse transcriptase inhibitors |
| 01/24/2008 | DE102006033362A1 Verfahren zur Herstellung von chiralen Aminocarbonylverbindungen A process for the preparation of chiral amino carbonyl compounds |
| 01/24/2008 | DE102006033321A1 Medizinische Verwendung von N-Phenylpropenoyl-Aminosäurederivaten und verwandten Verbindungen Medical use of N-phenylpropenoyl-amino acid derivatives and related compounds |
| 01/23/2008 | EP1879880A2 Dihydroxyphenylalanine derivatives |
| 01/23/2008 | EP1879855A2 Trpv1 agonist compounds and methods for making and using the same |
| 01/23/2008 | EP1879854A1 Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid |
| 01/23/2008 | EP1501801B1 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases |
| 01/23/2008 | CN101111471A Material for metallic-pattern formation, crosslinking monomer, and method of forming metallic pattern |
| 01/23/2008 | CN101111470A Crystalline acat (acyl-coa:cholesterol o-acyltransferase) inhibitor |
| 01/23/2008 | CN101108811A Method for synthesizing amine derivant of oleic acid |
| 01/23/2008 | CN100363332C Aromatic amino acid derivative and its prepn process and medicinal use |
| 01/22/2008 | US7321065 E.g., N-methyl-O-benzyl-tyramine, 3,5,3',5'-tetraiodothyroethanolamine; antagonist of a G protein coupled receptor and a trace amine receptor; antidepressants; nervous system disorders; antidiabetic agents; antiarrhymia disorders; glandular disorders of the thyroid; congestive heart failure; analgesics |
| 01/22/2008 | US7321001 carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer |
| 01/22/2008 | CA2495967C New synthesis process and new crystalline form for agomelatine, and pharmaceutical compositions containing it |
| 01/22/2008 | CA2232607C Process for the production of azomethines and alpha-haloacetanilides |
| 01/22/2008 | CA2172946C N-(.alpha.-alkylbenzylidene)-.alpha.-phenylalkylamine, its use and process for producing the same and process for producing intermediate |
| 01/17/2008 | WO2008008701A2 Substituted cyclopentane derivatives as therapeutic agents |
| 01/17/2008 | WO2008008700A2 Substituted cyclopentane derivatives as therapeutic agents |